Company Ticker News January 10, 2022This Hot Growth Stock Is Still a Buy After Enormous Gains 0 0 Share
Press Release January 10, 2022Moderna and Carisma Establish Collaboration to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology 0 0 Share
Press Release January 10, 2022Moderna and Carisma Establish Collaboration to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology 0 0 Share
Press Release January 10, 2022Moderna Announces Advances Across Its Industry-Leading mRNA Pipeline and Provides Business Update 0 0 Share
Company Ticker News January 10, 2022Moderna raises 2022 vaccine sales forecast to $18.5 billion 0 0 Share
Company Ticker News January 10, 2022Moderna's working with world health leaders on Covid booster that targets omicron for this fall, CEO says 0 0 Share
Company Ticker News January 10, 2022A universal flu vaccine may be the next big mRNA breakthrough for Moderna, Pfizer 0 0 Share